BIONIME Showcases iFree2 CGM at EASD 2026 in Milan Milan, Italy | EASD 2026 BIONIME is pleased to participate in EASD 2026, held at Allianz MiCo in Milan, Italy, showcasing its innovative iFree2 Continuous Glucose Monitoring (CGM) System to healthcare…
BIONIME Showcases iFree2 CGM in Singapore Singapore | Exhibition Highlights BIONIME successfully concluded its exhibition in Singapore, showcasing its latest continuous glucose monitoring solution, iFree2 CGM, to healthcare professionals, industry partners, and visitors from around the world. The event provided…
Bionime’s iFree2 CGM Obtains EU MDR Certification, Marking a New Milestone in Global Expansion Bionime Corporation’s next-generation iFree2 Continuous Glucose Monitoring (CGM) System has officially obtained certification under the European Union Medical Device Regulation (EU MDR). This certification confirms that the product meets…
2026 WHX Miami The Bionime team is making a strong impression at WHX Miami 2026, where healthcare professionals and industry partners from around the world are gathering to explore the latest innovations in medical technology.One of the highlights at our…
2026 ATTD Bionime Showcases RIGHTEST iFree 2 CGM at ATTD 2026, Highlighting Precision and Patient ComfortBarcelona, Spain — At ATTD 2026, Bionime is drawing significant attention with the presentation of its latest innovation, the RIGHTEST iFree 2 Continuous Glucose Monitoring…
2026 HIMSS Bionime Showcases RIGHTEST iFree 2 CGM at HIMSS 2026 in Las VegasLas Vegas, March 2026 — Bionime is participating in HIMSS 2026 at the Venetian Expo in Las Vegas, presenting its latest continuous glucose monitoring (CGM) solution, the…
2026 WHX Dubai Live from Dubai: Where Data Meets Real Life — Smart Healthcare in ActionDubai, UAE — Bionime captured global attention today at Booth S7.A99, where a dynamic atmosphere and continuous engagement with international partners highlighted the growing momentum…